The duration of exposure to HIV modulates the breadth and the magnitude of HIV-specific memory CD4+ T cells

Journal of Immunology

Volumn 178, Issue 2, 2007, Pages 788-797

  Younes, Souheil Antoine ^a   Trautmann, Lydie ^a   Yassine Diab, Bader ^a   Kalfayan, Lena H ^a   Kernaleguen, Anne Elen ^a   Cameron, Thomas O ^c   Boulassel, Rachid ^b   Stern, Lawrence J ^d   Routy, Jean Pierre ^b   Grossman, Zvi ^e,f   Dumont, Alain R ^a   Sekaly, Rafick Pierre ^a,b,g  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e TEL AVIV UNIVERSITY   (Israel)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIGEN; DIDANOSINE; EFAVIRENZ; GAG PROTEIN; INDINAVIR; LAMIVUDINE; NEF PROTEIN; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG TREATMENT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 33846195894     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.2.788     Document Type: Article

References (62)

1. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410: 980-987.
2. + T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12: 375-380.
3. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
4. + T-cell-deficient mice. J. Virol. 68: 4700-4704.
5. Nash, A. A. 2000. T cells and the regulation of herpes simplex virus latency and reactivation. J. Exp. Med. 191: 1455-1458.
6. Walter, E. A., P. D. Greenberg, M. J. Gilbert, R. J. Finch, K. S. Watanabe, E. D. Thomas, and S. R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333: 1038-1044.
7. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194: 1395-1406.
8. Wherry, E. J., K. A. Puorro, A. Porgador, and L. C. Eisenlohr. 1999. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163: 3735-3745.
9. Fuller, M. J., A. Khanolkar, A. E. Tebo, and A. J. Zajac. 2004. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172: 4204-4214.
10. Fuller, M. J., and A. J. Zajac. 2003. Ablation of CDS and CD4 T cell responses by high viral loads. J. Immunol 170: 477-486.
11. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol. 2: 415-422.
12. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
13. Khanolkar, A., M. J. Fuller, and A. J. Zajac. 2002. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol. Res. 26: 309-321.
14. + T cells. Nature 417: 95-98.
15. Pontesilli, O., S. Kerkhof-Garde, N. G. Pakker, D. W. Notermans, M. T. Roos, M. R. Klein, S. A. Danner, and F. Miedema. 1999. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection. Immunol. Lett. 66: 213-217.
16. Binley, J. M., D. S. Schiller, G. M. Ortiz, A. Hurley, D. F. Nixon, M. M. Markowitz, and J. P. Moore. 2000. The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type I infection with combination antiretroviral therapy. J. Infect. Dis. 181: 1249-1263.
17. Valentine, F. T., A. Paolino, A. Saito, and R. S. Holzman. 1998. Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease. AIDS Res. Hum. Retroviruses 14(Suppl 2): S161-S166.
18. Plana, M., F. Garcia, T. Gallart, J. M. Mira, and J. M. Gatell. 1998. Lack of T-cell proliferative response to HIV-1 antigens after I year of highly active antiretroviral treatment in early HIV-1 disease. Immunology Study Group of Spanish EARTH-1 Study. Lancet 352: 1194-1195.
19. Rinaldo, C. R., Jr., J. M. Liebmann, X. L. Huang, Z. Fan, Q. Al Shboul, D. K. McMahon, R. D. Day, S. A. Riddler, and J. W. Mellors. 1999. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. J. Infect. Dis. 179: 329-336.
20. Oxenius, A., D. A. Price, S. J. Dawson, H. F. Gunthard, M. Fischer, L. Perrin, E. Ramirez, C. Fagard, B. Hirschel, G. Scullard, et al. 2002. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load. AIDS 16: 2317-2322.
21. + T cell responses associated with control of viremia. Science 278: 1447-1450.
22. + T lymphocytes. Proc. Natl. Acad. Sci. USA 97: 3382-3387.
23. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
24. Carcelain, G., R. Tubiana, A. Samri, V. Calvez, C. Delaugerre, H. Agut, C. Katlama, and B. Autran. 2001. Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection. J. Virol. 75: 234-241.
25. Oxenius, A., D. A. Price, H. F. Gunthard, S. J. Dawson, C. Fagard, L. Perrin, M. Fischer, R. Weber, M. Plana, F. Garcia, et al. 2002. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection. Proc. Natl. Acad. Sci. USA 99: 13747-13752.
26. Kaufmann, D. E., P. M. Bailey, J. Sidney. B. Wagner, P. J. Norris, M. N. Johnston, L. A. Cosimi, M. M. Addo, M. Lichterfeld, M. Altfeld, et al. 2004. Comprehensive analysis of human immunodeficiency virus type I-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J. Virol. 78: 4463-4477.
27. + T cell proliferation. Proc. Natl. Acad. Sci. USA 98: 13878-13883.
28. + T cells and HIV-1- specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J. Virol. 76: 5925-5936.
29. + T cells endowed with proliferative capacity. J. Exp. Med. 198: 1909-1922.
30. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972.
31. Kaufmann, D. E., M. Lichterfeld, M. Altfeld, M. M. Addo, M. N. Johnston, P. K. Lee, B. S. Wagner, E. T. Kaufe, D. Strick, E. S. Rosenberg, and B. D. Walker. 2004. Limited durability of viral control following treated acute HIV infection. PLoS Med. 1: e36.
32. Emu, B., E. Sinclair, D. Favre, W. J. Moretto, P. Hsue, R. Hoh, J. N. Martin, D. F. Nixon, J. M. McCune, and S. G. Deeks. 2005. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment. J. Virol. 79: 14169-14178.
33. Harari, A., F. Vallelian, P. R. Meylan, and G. Pantaleo. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174: 1037-1045.
34. Harari, A. F., F. F. Vallelian, and G. Pantaleo. 2004. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 34: 3525-3533.
35. Machado, D. M., E. L. Delwart, R. S. Diaz, C. F. de Oliveira, K. Alves, B. D. Rawal, M. Sullivan, M. Gwinn, K. A. Clark, and M. P. Busch. 2002. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS 16: 113-119.
36. Janssen, R. S., G. A. Satten, S. L. Stramer, B. D. Rawal, T. R. O'Brien, B. J. Weiblen, F. M. Hecht, N. Jack, F. R. Cleghorn, J. O. Kahn, et al. 2001. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. J. Am. Med. Assoc. 280: 42-48.
37. + T cells with class II MHC oligomers. J. Immunol. Methods 268: 51-69.
38. Etongue-Mayer, P., M. A. Langlois, M. Ouellette, H. Li, S. Younes, R. Al Daccak, and W. Mourad. 2002. Involvement of zinc in the binding of Mycoplasma arthritidis-derived mitogen to the proximity of the HLA-DR binding groove regardless of histidine 81 of the β chain. Eur. J. Immunol. 32: 50-58.
39. + T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease. J. Infect, Dis. 182: 792-798.
40. Boaz, M. J., A. Waters, S. Murad, P. J. Easterbrook, E. D'Sousa, C. van Wheeley, and A. Vyakamam. 2003. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects. Clin. Exp. Immunol. 134: 454-463.
41. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364: 33-39.
42. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. Vignali. 1997. T cell receptor recognition of MHC class H-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-399.
43. Rotzschke, O., K. Falk, J. Mack, J. M. Lau, G. Jung, and J. L. Strominger. 1999. Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes. Proc. Natl. Acad. Sci. USA 96: 7445-7450.
44. + T cell response. J. Exp. Med. 201: 1555-1565.
45. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
46. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
47. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193: 169-180.
48. Lacabaratz-Porret, C., A. Urrutia, J. M. Doisne, C. Goujard, C. Deveau, M. Dalod, L. Meyer, C. Rouzioux, J. F. Delfraissy, A. Venet, and M. Sinet. 2003. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. J. Infect. Dis. 187: 748-757.
49. Routy, J. P., P. Vanhems, D. Rouleau, C. Tsoukas, E. Lefebvre, P. Cote, R. LeBlanc, B. Conway, M. Alary, J. Bruneau, and R. P. Sekaly. 2000. Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use. J. Acquired Immune Defic. Syndr. 24: 425-432.
50. + T cells and viremia: who's in control? Trends Immunol. 27: 119-124.
51. + T cells. J. Immunol 170: 822-829.
52. + T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
53. Day, C. L., D. E. Kaufmann, P. Kiepiela, J. A. Brown, E. S. Moodley, S. Reddy, E. W. Mackey, J. D. Miller, A. J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443: 350-354.
54. + T cell survival in HIV infection. J. Exp. Med. 203: 2281-2292.
55. + T cells. Nature 434: 1148-1152.
56. Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183-188.
57. Haase, A. T., K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z. Q. Zhang, et al. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274: 985-989.
58. Dion, M. L., J. F. Poulin, R. Bordi, M. Sylvestre, R. Corsini, N. Kettaf, A. Dalloul, M. R. Boulassel, P. Debre, J. P. Routy, et al. 2004. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 21: 757-768.
59. + T-cell Responses in HIV-infected subjects with sustained virologic control after highly active antiretroviral therapy. J. Acquired Immune Defic. Syndr. 36: 594-599.
60. + T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J. Immunol. 173: 2184-2189.
61. + T-lymphocyte nadir and the effect of highly active antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection. Clin. Immunol. 102: 154-161.
62. Miller, V., A. N. Phillips, B. Clotet, A. Mocroft, B. Ledergerber, O. Kirk, V. Ormaasen, P. Gargalianos-Kakolyris, S. Vella, and J. D. Lundgren. 2002. Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts. J. Infect. Dis. 186: 189-197.